JHVEPhoto/iStock Editorial via Getty Images Zimmer Biomet ( NYSE: ZBH ) is down for the third trading session in a row despite announcing a distribution agreement with THINK Surgical for the latter's TMINI Miniature Robotic System for total knee arthroplasty. Zimmer Biomet noted that TMINI complements its own ROSA Robotics portfolio "with a handheld robotic option that enables accurate implant placement to a predetermined CT-based, three-dimensional surgical plan." The company plans on rolling out TMINI to select U.
S. markets in the second half of the year. Baird analyst Jeff Johnson said that while some investors may be concerned the deal could undermine the ROSA Robotics portfolio, discussions with management indicate that Zimmer Biomet ( ZBH ) is not moving away from ROSA.
More on Zimmer Biomet Zimmer Biomet Holdings: Moving Along Argus upgrades Zimmer to buy, cites new products Zimmer Biomet Holdings, Inc. (ZBH) Q1 2024 Earnings Call Transcript Zimmer Biomet Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Zimmer Biomet.
